Cart
sales@molnova.com
Caesappanin C
CAS No. 1913319-59-1
Caesappanin C ( —— )
Catalog No. M23869 CAS No. 1913319-59-1
Caesappanin C, extracted from the heartwood of Indonesian Caesalpinia sappan L., shows strong proliferation stimulating activity against the primary osteoblastic cells in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 288 | In Stock |
|
| 10MG | 428 | In Stock |
|
| 25MG | 701 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCaesappanin C
-
NoteResearch use only, not for human use.
-
Brief DescriptionCaesappanin C, extracted from the heartwood of Indonesian Caesalpinia sappan L., shows strong proliferation stimulating activity against the primary osteoblastic cells in vitro.
-
DescriptionCaesappanin C, extracted from the heartwood of Indonesian Caesalpinia sappan L., shows strong proliferation stimulating activity against the primary osteoblastic cells in vitro.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1913319-59-1
-
Formula Weight608.6
-
Molecular FormulaC32H32O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC1=C(O)C=C2C(C3=CC=C(O)C=C3OC[C@](O)(CC4=CC(O)=C(O)C=C4C5=CC=C(O)C=C5OC[C@@](CO)(O)C2)CO)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Subehan, et al. Phytochemical investigation of the active constituents from
molnova catalog
related products
-
Matairesinoside
Matairesinoside is a natural product from Styrax japonica.
-
Delsoline
Delsoline is not only effective in preventing ventricular fibrillation and arrythmia, but can raise the intebsity of the threthold of electrical shocks to cause ventricular fibrillation in rabbits.
-
glatiramer Acetate
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS).
